<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04976725</url>
  </required_header>
  <id_info>
    <org_study_id>10354421-2021/03-13</org_study_id>
    <nct_id>NCT04976725</nct_id>
  </id_info>
  <brief_title>Comparison of Craniosacral Therapy and Myofacial Relaxation Techniques in People Diagnosed With Migraine</brief_title>
  <official_title>Comparison of the Effectiveness of Craniosacral Therapy and Myofacial Relaxation Techniques in People Diagnosed With Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alanya Alaaddin Keykubat University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alanya Alaaddin Keykubat University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Headache is a neurological condition that is very common all over the world and is observed&#xD;
      at some time in life in more than 90% of society. Migraine headache, known for thousands of&#xD;
      years, is one of the oldest diseases of humanity. The word 'hemicrania', meaning 'half of a&#xD;
      head', is used due to unilateral pain. Approaches to treating migraine include medication,&#xD;
      relaxation, biofeedback, living a regular life, adequate sleep, exercise, and stress&#xD;
      management. Neck pain is especially common in migraine patients. Exercise, manual practices,&#xD;
      electrop novelties are used to reduce musculoskeletal problems, thus reducing the effects of&#xD;
      migraine. Myofascial relaxation techniques, which are included in the manipulative techniques&#xD;
      in the literature, are relaxation methods performed on myofascial trigger points.Osteopathic&#xD;
      manual therapy (OMT) , which has recently entered the literature, 19. osteopathy, developed&#xD;
      by Andrew Taylor STILL at the end of the century, is a treatment system characterized by&#xD;
      focusing on integrity and using it by hand to heal diseases.The study of cranial OMM kraniyum&#xD;
      first anatomical and physiological mechanisms for the prevention and treatment of disease as&#xD;
      a whole is concerned with the relationship of the body, including diagnostic and therapeutic&#xD;
      methods.It is used in the treatment of somatic dysfunction of the head and other body parts.&#xD;
      An important component of cranial Omm is the primary respiratory mechanism, which occurs as&#xD;
      movement of the head bones, sacrum, dural membranes, central nervous system and cerebrospinal&#xD;
      fluid. The primary respiratory mechanism is synchronous with the cranial rhythmic impulse, a&#xD;
      2-phase rhythmic cycle that represents a dynamic metabolic exchange with each stage of the&#xD;
      body. This cycle is indicated as loops between 7 and 14 per minute.Fascial mobilization&#xD;
      therapy increases energy use in segments implemented by mechanical changes.Accordingly, it&#xD;
      helps to reduce the spasm of these layers extending fascially, to dissolve adhesions, and to&#xD;
      increase the range of motion of the joint.&#xD;
&#xD;
      H0: Osteopathic Manipulative Therapy has no effect on migraine symptoms. H1: Osteopathic&#xD;
      Manipulative Therapy has an effect on migraine symptoms. H2: myofascial relaxation techniques&#xD;
      have no effect on migraine symptoms. H3: methods of Osteopathic Manipulative Therapy have an&#xD;
      effect on migraine symptoms.&#xD;
&#xD;
      H4: myofascial relaxation techniques and osteopathic manipulative treatment methods have no&#xD;
      superiority over each other.&#xD;
&#xD;
      H5: myofascial relaxation techniques and osteopathic manipulative treatment methods have&#xD;
      superiority over each other.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 10, 2021</start_date>
  <completion_date type="Actual">September 20, 2021</completion_date>
  <primary_completion_date type="Actual">September 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>75 individuals will be included in our study, including 3 groups: control group (N= 25), osteopathic manipulative technique (n= 25), myofascial relaxation group (n=25). Which group of individuals will be determined by randomizing them with closed envelope method.&#xD;
Osteopathic Manipulative Therapy and myofascial relaxation treatment applications will be applied 2 days a week, for periods of 30 min for 4 weeks.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Severity</measure>
    <time_frame>4 weeks , evaluation will be apply at the beginning and after treatment</time_frame>
    <description>Pain severity: the visual Analog scale (VAS) will be used to determine the pain severity of cases during rest and activity, the cases will be divided into 10 equal parts of 100 mm and the number values placed between 0 and 10 on the horizontal line will be described. &quot;I don't have any pain&quot; was announced as 0 points, &quot;unbearable pain&quot; was announced as 10 points, &quot;moderate pain&quot; was announced as 5 points. They will be asked to mark one of the values in accordance with these descriptions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>24-Hour Daily Life Scale In Migraines</measure>
    <time_frame>4 weeks , evaluation will be apply at the beginning and after treatment</time_frame>
    <description>The validity and reliability of the &quot;24-hour migraine quality of life scale&quot;, developed to determine changes in their quality of life within 24 hours after the first dose of the migraine drug they received after the onset of migraine headache, was examined for Turkish society.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Migraine Disability Index</measure>
    <time_frame>4 weeks , evaluation will be apply at the beginning and after treatment</time_frame>
    <description>MIDAS is a scale that has been developed to measure headache-related yeti loss and to improve patient-doctor communication about the functional consequences of migraine.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Corbin Posture Analysis</measure>
    <time_frame>4 weeks , evaluation will be apply at the beginning and after treatment</time_frame>
    <description>Anterior, posterior and lateral posture analysis of individuals Corbin posture analysis will be performed. Anterior tilt of the head, rounded back, shoulder protraction, kyphosis, lordosis, abdominal sagging, Genu recurvatum, lateral tilt of the head, protrusion of the scapula and scoliosis will be evaluated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cranial Analysis</measure>
    <time_frame>4 weeks , evaluation will be apply at the beginning and after treatment</time_frame>
    <description>The presence of asymmetry on the face will be evaluated together with parallel lines passing through the eyes, nose and lip on the face</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cervikal Range of Motion</measure>
    <time_frame>4 weeks , evaluation will be apply at the beginning and after treatment</time_frame>
    <description>Cervical region normal joint movement (NEH), cervical region extension, rotation, flexion and lateral flexion motion angles will be measured with universal goniometer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trigger Point Palpation</measure>
    <time_frame>4 weeks , evaluation will be apply at the beginning and after treatment</time_frame>
    <description>The trigger point in the chewing and neck muscles will be investigated by fingertip palpation in a stretched muscle.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Migraine Disorders</condition>
  <arm_group>
    <arm_group_label>Ostepathic manipulative treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The effects of osteopathy treatment method on the migraine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Myofascial relaxation Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The effects of myofascial treatment method on the migraine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Control group will have just medication treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Osteopathic Manipulative Therapy</intervention_name>
    <description>75 individuals will be included in our study, including 3 groups: control group (N= 25), osteopathic manipulative technique (n= 25), myofascial relaxation group (n=25). Which group of individuals will be determined by randomizing them with closed envelope method.&#xD;
Osteopathic Manipulative Therapy and myofascial relaxation treatment applications will be applied 2 days a week, for periods of 30 min for 4 weeks.</description>
    <arm_group_label>Control treatment</arm_group_label>
    <arm_group_label>Myofascial relaxation Treatment</arm_group_label>
    <arm_group_label>Ostepathic manipulative treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Age 18-65 Diagnosed with chronic migraine Patients who have recently been diagnosed with&#xD;
        chronic migraine who have not taken any medications so far for migraines.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Those in the drug group had a decommissioning of drug use for 4 weeks Suspicion or presence&#xD;
        of pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alanyaaku</name>
      <address>
        <city>Antalya</city>
        <state>Alanya</state>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>https://doi.org/10.1016/J.JCM.2019.12.001</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>http://www.biomedcentral.com/1472-6882/8/28</url>
    <description>Related Info</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 9, 2021</study_first_submitted>
  <study_first_submitted_qc>July 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2021</study_first_posted>
  <last_update_submitted>November 6, 2021</last_update_submitted>
  <last_update_submitted_qc>November 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Alanya Alaaddin Keykubat University</investigator_affiliation>
    <investigator_full_name>Ay√ßa Araci</investigator_full_name>
    <investigator_title>Physical Therapist, pHd</investigator_title>
  </responsible_party>
  <keyword>migraine, osteopathic maniulative treatment, myofascial release, physiotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>YES</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>Statistical Analysis Plan</doc_type>
      <doc_url>https://doi.org/10.1016/J.JCM.2019.12.001</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

